Triple

T18234607
Position Surface form Disambiguated ID Type / Status
Subject cimetidine E436638 entity
Predicate actsOn P9769 FINISHED
Object histamine H2 receptor NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: histamine H2 receptor | Statement: [cimetidine, actsOn, histamine H2 receptor]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: histamine H2 receptor
Context triple: [cimetidine, actsOn, histamine H2 receptor]
  • A. H2 receptor antagonist cimetidine
    H2 receptor antagonist cimetidine is a pioneering anti-ulcer medication that reduces stomach acid production by blocking histamine H2 receptors in the gastric parietal cells.
  • B. M2 muscarinic acetylcholine receptor
    The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
  • C. somatostatin receptor
    A somatostatin receptor is a G protein–coupled membrane receptor that binds the peptide hormone somatostatin to inhibit hormone secretion and modulate neurotransmission and cell proliferation.
  • D. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • E. H-2
    H-2 is an Interstate Highway in Hawaii that connects Honolulu with the central part of Oʻahu, including the city of Wahiawā and the vicinity of Schofield Barracks.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: histamine H2 receptor
Target entity description: The histamine H2 receptor is a G protein–coupled receptor primarily found in the stomach that mediates gastric acid secretion and is targeted by H2-blocker drugs used to treat ulcers and reflux.
  • A. H2 receptor antagonist cimetidine
    H2 receptor antagonist cimetidine is a pioneering anti-ulcer medication that reduces stomach acid production by blocking histamine H2 receptors in the gastric parietal cells.
  • B. M2 muscarinic acetylcholine receptor
    The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
  • C. somatostatin receptor
    A somatostatin receptor is a G protein–coupled membrane receptor that binds the peptide hormone somatostatin to inhibit hormone secretion and modulate neurotransmission and cell proliferation.
  • D. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • E. H-2
    H-2 is an Interstate Highway in Hawaii that connects Honolulu with the central part of Oʻahu, including the city of Wahiawā and the vicinity of Schofield Barracks.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8b9103a8081908bbb0836fef10efd completed April 10, 2026, 8:47 a.m.
NER Named-entity recognition batch_69e4f4b5ce608190b6fba518256607da completed April 19, 2026, 3:28 p.m.
Created at: April 10, 2026, 10:33 a.m.